The Chinese NDRC imposes heavy fines on two pharmaceutical companies for monopoly pricing (Shuntong / Huaxin)

KEYWORDS
Reference
Chinese NDRC, Shuntong / Huaxin, 15 November 2011 (Chinese)

The NDRC has imposed fines of almost CNY 7 million, confiscated illegal gains, and imposed a cease-and-desist order on two pharmaceutical companies for monopoly pricing. The decision is the first

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • University of Melbourne
    Australia 103 contributions 28199 visits
  • China Competition Bulletin (Beijing)
    China 101 contributions 25145 visits
  • Institute of American Studies (Beijing)
    China 52 contributions 14750 visits

Quotation

Allan Fels, Xiaoye Wang, Jessica Su, The Chinese NDRC imposes heavy fines on two pharmaceutical companies for monopoly pricing (Shuntong / Huaxin), 15 November 2011, e-Competitions November 2011, Art. N° 74338

Visites 167

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues